Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis
Clinics in Liver Disease · 2026-05 · 30 (2) · 557-569
DOI: 10.1016/j.cld.2026.01.013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2026-05. Verfasst von George Papatheodoridis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greece. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Hepatitis, Viral, Human, Hepatitis Viruses. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Coexistence of metabolic dysfunction-associated steatotic liver disease and chronic hepatitis B (HBV) or C virus (HCV) infection is not uncommon. Hepatic steatosis without metabolic dysfunctions may have favorable effects on HBV increasing HBV surface antigen loss and preventing fibrosis progression, while steatohepatitis with metabolic dysfunctions increases the risk of fibrosis progression and hepatocellular carcinoma. In HCV genotype 3, hepatic steatosis is virus-induced and improves/resolves after viral clearance, while it is metabolic driven in other HCV genotypes persisting after viral clearance and contributing to ongoing liver injury. Treatment of metabolic parameters is mandatory for optimal management of patients with HCV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greece.
- Department of Internal Medicine, Hospital Quiron Salud, Barcelona, Spain.
- Hospital Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Universitat Autònoma de Barcelona, Spain; Centro de Investigación Bio…
Zitieren
APA
Papatheodoridis, G., Lekakis, V., Esteban, R., & Buti, M. (2026). Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis. Clinics in Liver Disease, 30(2), 557-569. https://doi.org/10.1016/j.cld.2026.01.013
Vancouver
Papatheodoridis G, Lekakis V, Esteban R, Buti M. Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis. Clinics in Liver Disease. 2026;30(2):557-569. doi:10.1016/j.cld.2026.01.013
BibTeX
@article{Papatheodoridis2026,
author = {Papatheodoridis, George and Lekakis, Vasileios and Esteban, Rafael and Buti, Maria},
title = {Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis},
journal = {Clinics in Liver Disease},
year = {2026},
volume = {30},
number = {2},
pages = {557--569},
doi = {10.1016/j.cld.2026.01.013}
}
EUVIMED